WallStreetZenWallStreetZen

NASDAQ: OCGN
Ocugen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for OCGN

Based on 3 analysts offering 12 month price targets for Ocugen Inc

Min Forecast
$7.00+600%
Avg Forecast
$9.17+816.7%
Max Forecast
$11.00+1,000%

Should I buy or sell OCGN stock?

Based on 3 analysts offering ratings for Ocugen Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
1 analysts 33.33%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although OCGN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates OCGN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their OCGN stock forecasts and price targets.

OCGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-10
lockedlocked$00.00+00.00%2026-05-27
lockedlocked$00.00+00.00%2026-03-25

1 of 1

Forecast return on equity

Is OCGN forecast to generate an efficient return?

Company
-717.3%
Industry
22.6%
Market
168.99%
OCGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is OCGN forecast to generate an efficient return on assets?

Company
95.61%
Industry
23.77%
OCGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

OCGN earnings per share forecast

What is OCGN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.26
Avg 2 year Forecast
-$0.27
Avg 3 year Forecast
-$0.02

OCGN revenue forecast

What is OCGN's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$4.8M+5.87%
Avg 2 year Forecast
$2.6M-44.32%
Avg 3 year Forecast
$145.5M+3,075.76%
OCGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

OCGN revenue growth forecast

How is OCGN forecast to perform vs Biotechnology companies and vs the US market?

Company
197.17%
Industry
31.01%
Market
13.91%
OCGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
OCGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

OCGN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OCGN$1.00$9.17+816.70%Strong Buy
YDES$4.77N/AN/A
BNTC$9.64$21.00+117.84%Buy
LRMR$3.32$9.60+189.16%Buy
ENTA$12.00$20.00+66.67%Buy
View Top Biotech Stocks

Ocugen Stock Forecast FAQ

Is Ocugen Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: OCGN) stock is to Strong Buy OCGN stock.

Out of 3 analysts, 2 (66.67%) are recommending OCGN as a Strong Buy, 1 (33.33%) are recommending OCGN as a Buy, 0 (0%) are recommending OCGN as a Hold, 0 (0%) are recommending OCGN as a Sell, and 0 (0%) are recommending OCGN as a Strong Sell.

If you're new to stock investing, here's how to buy Ocugen stock.

What is OCGN's earnings growth forecast for 2026-2028?

(NASDAQ: OCGN) Ocugen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.85%.

Ocugen's earnings in 2026 is -$81,811,000.On average, 8 Wall Street analysts forecast OCGN's earnings for 2026 to be -$87,049,640, with the lowest OCGN earnings forecast at -$93,051,894, and the highest OCGN earnings forecast at -$74,773,843. On average, 6 Wall Street analysts forecast OCGN's earnings for 2027 to be -$92,543,228, with the lowest OCGN earnings forecast at -$119,638,149, and the highest OCGN earnings forecast at -$64,091,866.

In 2028, OCGN is forecast to generate -$7,765,628 in earnings, with the lowest earnings forecast at -$142,901,123 and the highest earnings forecast at $217,200,212.

What is OCGN's revenue growth forecast for 2026-2028?

(NASDAQ: OCGN) Ocugen's forecast annual revenue growth rate of 197.17% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.91%.

Ocugen's revenue in 2026 is $4,580,000.On average, 8 Wall Street analysts forecast OCGN's revenue for 2026 to be $1,644,346,334, with the lowest OCGN revenue forecast at $996,984,579, and the highest OCGN revenue forecast at $2,172,002,118. On average, 6 Wall Street analysts forecast OCGN's revenue for 2027 to be $864,731,523, with the lowest OCGN revenue forecast at $0, and the highest OCGN revenue forecast at $2,136,395,526.

In 2028, OCGN is forecast to generate $49,323,607,825 in revenue, with the lowest revenue forecast at $4,586,129,063 and the highest revenue forecast at $144,756,056,875.

What is OCGN's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: OCGN) forecast ROA is 95.61%, which is higher than the forecast US Biotechnology industry average of 23.77%.

What is OCGN's Price Target?

According to 3 Wall Street analysts that have issued a 1 year OCGN price target, the average OCGN price target is $9.17, with the highest OCGN stock price forecast at $11.00 and the lowest OCGN stock price forecast at $7.00.

On average, Wall Street analysts predict that Ocugen's share price could reach $9.17 by Sep 10, 2027. The average Ocugen stock price prediction forecasts a potential upside of 816.7% from the current OCGN share price of $1.00.

What is OCGN's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: OCGN) Ocugen's current Earnings Per Share (EPS) is -$0.26. On average, analysts forecast that OCGN's EPS will be -$0.26 for 2026, with the lowest EPS forecast at -$0.27, and the highest EPS forecast at -$0.22. On average, analysts forecast that OCGN's EPS will be -$0.27 for 2027, with the lowest EPS forecast at -$0.35, and the highest EPS forecast at -$0.19. In 2028, OCGN's EPS is forecast to hit -$0.02 (min: -$0.42, max: $0.64).

What is OCGN's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: OCGN) forecast ROE is -717.3%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.